Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Diabetes / Metabolic Neurology Rheumatology Women's Health Mental Health / Psychiatry Dermatology Rare Diseases Men's Health
Clinical Trial ● Currently Recruiting Non-phase study NCT06789406

PMCF Study of the Axonics SNM System Model 5101 (R20) for the Indication of OAB

PMCF Study of the Axonics SNM System Model 5101 (R20) for the Indication of OAB — Recruiting • Non-phase study • NCT06789406.

📅 15 Jun 2026 ⏱ 1 min read
Currently Recruiting
This trial is actively seeking participants in the UK. Discuss eligibility with your patient before referring.
Status
Currently Recruiting
Phase
Non-phase study
NCT ID
NCT06789406
Start
2025-09-18
Completion
2027-01
ClinicaliQ Trial Snapshot
  • PMCF Study of the Axonics SNM System Model 5101 (R20) for the Indication of OAB — Recruiting • Non-phase study • NCT06789406.
  • A long-term safety and effectiveness study of the Axonics sacral nerve stimulation device for overactive bladder.

Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.

Use This Page For
  • Quick orientation before opening the registry record.
  • Checking recruitment status, phase and sponsor at a glance.
  • Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying

Post-market clinical follow-up for continued assessment of safety and performance to confirm long-term outcomes of the Axonics SNM System INS Model 5101. Conditions: Urinary Urge Incontinence (UUI), Urinary Frequency (UF), Overactive Bladder (OAB) Interventions: Axonics SNM System INS Model 5101 (R20) Lead Sponsor: Axonics, Inc. Planned Enrollment: 55 participants

Full Trial Details
View this trial on the source registry
Eligibility criteria, protocol, and results when available
View Trial ↗
Share: Twitter/X LinkedIn